2015
DOI: 10.1007/s10269-015-2529-9
|View full text |Cite
|
Sign up to set email alerts
|

AERIO news in brief

Abstract: Efficacité et toxicité du nivolumab, un anticorps anti-PD-1, chez les patients ayant un carcinome épidermoïde pulmonaire réfractaire (CheckMate 063) : un essai de phase II monobras Rizvi NA, Mazières J, Planchard D, et al. (2015) Lancet Oncol 16: 257-65 E.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 13 publications
(15 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?